Form 8-K - Current report:
SEC Accession No. 0001493152-24-009959
Filing Date
2024-03-14
Accepted
2024-03-14 16:12:57
Documents
15
Period of Report
2024-03-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 108405
2 ex3-1.htm EX-3.1 14372
  Complete submission text file 0001493152-24-009959.txt   312158

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE age-20240314.xsd EX-101.SCH 3009
4 XBRL LABEL FILE age-20240314_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE age-20240314_pre.xml EX-101.PRE 22356
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3873
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24750265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)